Technical Specialist
Lin has experience drafting and prosecuting patent applications, managing and counseling clients on large global portfolios, conducting freedom-to-operate analyses, performing competitive landscape evaluations, and providing patentability, validity, and infringement opinions. Her practice further extends to assisting with post-grant proceedings, including inter partes reviews (IPRs), before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO).
Lin has a wide range of scientific research expertise, most notably in the areas of cancer biology, immuno-oncology, drug discovery, and pharmaceutical sciences. Prior to joining Finnegan, Lin completed a postdoctoral fellowship at the Dana-Farber Cancer Institute and Harvard Medical School, where she investigated epigenetic factors important for establishing the tumor immune microenvironment in melanoma using CRISPR screening. Following her postdoctoral training, Lin held a business development and licensing associated position in the Dana-Farber Innovation Office, where she performed due diligence on the commercialization potential of technologies and led internal and external marketing efforts to promote research discoveries.
Commentary
The 2023 WIPL Awards: Law Firm Lifetime Achievement The 2023 WIPL Awards: Law Firm Lifetime Achievement
November 20, 2023
Law.comDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.